Precise Nitinol Stent System
PMA P030047
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP030047 | Date22 Sep 2006 | StatusActive |
Official records
- FDA PMA database P030047
Recalls
-
- Ongoing Z-0729-2020
Cordis has initiated a labeling correction for S.M.A.R.T. and PRECISE stents due to incorrect MRI information on the IFU. The correct classification is "MRI Conditional" not "MRI Safe".
-
- Completed Z-1257-2021
Distal tip may become separated from the lumen wire in specific lots.
-
- Terminated Z-1946-2016
- Terminated Z-1947-2016
Inability to deploy the stent or partial stent deployment.
Timeline
- Approved FDA PMA P030047
- Recall initiated FDA recalls Z-1946-2016
- Recall initiated FDA recalls Z-1947-2016
- Recall initiated FDA recalls Z-0729-2020
- Recall initiated FDA recalls Z-1257-2021
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Full name
- Precise Nitinol Stent System/Precise Rx Nitinol Stent System/Precise Pro Rx Nitinol Stent System
- Trade name
- Cordis Precise Nitinol Stent System
- Generic name
- Stent, carotid
- PMA number
- FDA product code
- NIM
- Device class
- Class III
- Advisory committee
- Cardiovascular
- FDA decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
The Precise Nitinol Stent System is a carotid stent designed for the treatment of patients who require carotid revascularization. It is indicated for use in conjunction with the AngioGuard XP emboli capture guidewire for patients at high risk for adverse events from carotid endarterectomy.
This device is intended for patients with specific stenosis criteria in the common or internal carotid artery and requires a vessel diameter of 4-9mm at the target lesion. The system is available in 5.5 Fr and 6.0 Fr sizes in an over-the-wire configuration. It has received FDA PMA approval for clinical use.